Investigating the Effects of O-GlcNAc Modifications in Parkinson’s Disease Using Semisynthetic α-Synuclein
- 7 March 2020
- book chapter
- Published by Springer Nature
- Vol. 2133, 313-326
Abstract
α-Synuclein is a small aggregation-prone protein associated with Parkinson’s disease (PD). The protein’s biochemical and biophysical properties can be heavily influenced by various types of posttranslational modification (PTMs) such as phosphorylation, ubiquitination, and glycosylation. To understand the site-specific effects of various PTMs have on the protein and its aggregation, obtaining a homogeneous sample of the protein of interest with the specific modification of interest is key. Expressed protein ligation (EPL) has emerged as robust tool for building synthetic proteins bearing site-specific modifications. Here, we outline our approach for building α-synuclein with site specific O-GlcNAc modifications, an intracellular subtype of glycosylation that has been linked to the inhibition of protein aggregation. More specifically, we provide specific protocols for the synthesis of α-synuclein bearing an O-GlcNAc modification at threonine 72, termed α-synuclein(gT72). However, this general approach utilizing two recombinant fragments and one synthetic peptide is applicable to other sites and types of modifications and should be transferable to various other protein targets, including aggregation prone proteins like tau and TDP-43.Keywords
This publication has 31 references indexed in Scilit:
- α-Synuclein O-GlcNAcylation alters aggregation and toxicity, revealing certain residues as potential inhibitors of Parkinson’s diseaseProceedings of the National Academy of Sciences, 2019
- A Chemoenzymatic Histology Method for O‐GlcNAc DetectionChemBioChem, 2017
- O-GlcNAc modification blocks the aggregation and toxicity of the protein α-synuclein associated with Parkinson's diseaseNature Chemistry, 2015
- Composition of isolated synaptic boutons reveals the amounts of vesicle trafficking proteinsScience, 2014
- Alpha-synuclein Post-translational Modifications as Potential Biomarkers for Parkinson Disease and Other SynucleinopathiesMolecular & Cellular Proteomics, 2013
- The many faces of α-synuclein: from structure and toxicity to therapeutic targetNature Reviews Neuroscience, 2012
- Remodeling of Lipid Vesicles into Cylindrical Micelles by α-Synuclein in an Extended α-Helical ConformationJournal of Biological Chemistry, 2012
- Membrane Curvature Induction and Tubulation Are Common Features of Synucleins and ApolipoproteinsJournal of Biological Chemistry, 2010
- Ogt-Dependent X-Chromosome-Linked Protein Glycosylation Is a Requisite Modification in Somatic Cell Function and Embryo ViabilityMolecular and Cellular Biology, 2004
- Expressed protein ligation: A general method for protein engineeringProceedings of the National Academy of Sciences, 1998